Only pay if approved·Free shipping·Cancel anytime·Provider supervised·HIPAA secure

Provider-prescribed treatments. Subject to medical evaluation. Medications are dispensed by licensed U.S. pharmacies.

Back to Blog
GLP-1 / Weight Loss
📚 Informational 5/13/2026 7 min readBy EdenRx Medical Team

Obesity Treatment History: From Fad Diets to GLP-1 Medications

Obesity Treatment History: From Fad Diets to GLP-1 Medications

Ready to find out if you may qualify?

No payment required to start · Takes less than 60 seconds · Only pay if approved

Check Your Eligibility Free
No Payment Required Response Within 24h Built from Eden Med Spa

Key Takeaways

  • 1Obesity treatment has evolved from dangerous fad diets and amphetamine-based pills to clinically validated GLP-1 receptor agonists over the past century.
  • 2GLP-1 medications like semaglutide may produce 15–22% body weight reduction in eligible patients, results previously seen only with bariatric surgery.
  • 3Provider-reviewed telehealth platforms like EdenRx make evidence-based GLP-1 programs accessible to qualifying patients in Florida and New York without an in-person visit.

The history of obesity treatment is a story of trial, error, and hard-won scientific progress — ultimately arriving at GLP-1 receptor agonists, a class of medications that are reshaping how clinicians and patients approach long-term weight management. Understanding the obesity treatment history GLP-1 era emerged from helps put today's evidence-based options in proper context.

Ready to find out if you qualify? Start Free Assessment — No payment required.

The Early Era: Fad Diets and Dangerous Quick Fixes

For most of recorded history, weight loss was treated as a matter of willpower rather than medicine. The 19th and early 20th centuries saw the rise of extreme dietary fads — from the "Banting Diet" in the 1860s (a proto-low-carb plan) to the "cigarette diet" of the 1920s, which actually encouraged smoking to suppress appetite. These approaches reflected a cultural misunderstanding of obesity as a moral failing rather than a complex, chronic medical condition.

By mid-century, the medical community began recognizing that dietary advice alone produced inconsistent results. Crash diets, liquid protein fasts, and caloric restriction regimens became popular in the 1960s and 1970s, some resulting in serious health complications including cardiac events. These early failures made one thing clear: sustainable obesity treatment would require a far more sophisticated understanding of human metabolism and appetite regulation.

Amphetamines, Fen-Phen, and the Risks of Early Weight Loss Drugs

The pharmaceutical era of obesity treatment began in the 1930s with amphetamine-based appetite suppressants. These medications did produce weight loss, but at a severe cost — addiction, cardiovascular strain, and widespread abuse made them a public health problem rather than a solution. By the 1970s, strict federal controls had curtailed their use, but the appetite for a "magic pill" persisted.

The most cautionary chapter came in the 1990s with Fen-Phen (fenfluramine-phentermine), a drug combination that was wildly popular before it was pulled from the market in 1997 after being linked to heart valve damage and pulmonary hypertension. Rimonabant, a cannabinoid receptor blocker approved in Europe in the mid-2000s, was similarly withdrawn after serious psychiatric side effects emerged. Each of these setbacks reinforced the need for rigorous, long-term safety data before any weight loss medication could be trusted for widespread use.

The Surgical Era and the Limits of Bariatric Procedures

With medications proving unreliable, bariatric surgery emerged as the most effective intervention for severe obesity through the late 20th century. Procedures like gastric bypass and gastric banding demonstrated significant and durable weight loss in clinical settings, fundamentally changing how obesity was classified — from a lifestyle issue to a serious, treatable disease. The success of bariatric surgery was instrumental in pushing the medical community toward viewing obesity through a biological lens.

However, surgery carries real limitations. It is invasive, expensive, irreversible in many forms, and requires patients to meet strict BMI and health criteria. Many individuals with clinically significant obesity do not qualify, cannot afford the procedure, or are unwilling to undergo the associated risks and lifestyle adjustments. The surgical era proved that biological intervention works — it just wasn't accessible enough to address the scale of the obesity epidemic. Explore who qualifies for weight loss medication to understand today's more accessible eligibility thresholds.

The GLP-1 Revolution: Science Finally Catches Up

The discovery of glucagon-like peptide-1 (GLP-1) receptor agonists represents arguably the most significant breakthrough in metabolic medicine in decades. Originally developed to treat type 2 diabetes, drugs like semaglutide and tirzepatide were found to produce remarkable reductions in body weight by mimicking a gut hormone that regulates insulin secretion, slows gastric emptying, and — critically — signals the brain to reduce hunger and increase satiety. Clinical trials showed average weight reductions of 15–22% of body weight, numbers previously seen only with bariatric surgery.

The FDA approval of semaglutide (Wegovy) for chronic weight management in 2021 marked a watershed moment in obesity treatment history. GLP-1 medications are now at the center of evidence-based weight loss care, prescribed not as a shortcut but as a medically supervised tool for patients who qualify. At EdenRx, our GLP-1 weight loss program is built around provider-reviewed protocols designed to support eligible patients in Florida and New York. Results vary by individual, and these medications are most effective when combined with nutritional guidance and lifestyle support.

Telehealth and the Democratization of Weight Loss Care

Even the best medications are ineffective if patients cannot access them. One of the most transformative developments alongside GLP-1 therapy has been the rise of telehealth — making provider-reviewed weight loss care available without requiring in-person clinic visits. For millions of Americans in underserved communities, rural areas, or simply time-constrained situations, telehealth bridges the gap between need and access.

Platforms like EdenRx bring together licensed medical providers, evidence-based prescribing protocols, and ongoing patient support entirely online. Patients can explore weight loss options online, complete a clinical assessment, and — if eligible — receive a personalized treatment plan that may include GLP-1 medications. Transparent pricing and flexible programs mean that cost and convenience are no longer barriers to medically supervised care. This is what the entire arc of obesity treatment history has been building toward: the right treatment, for the right patient, delivered where they are.

Why Provider Review Matters

Not every weight loss solution you find online is supervised by a licensed medical professional — and in the context of medications like GLP-1 receptor agonists, that distinction is critical. These are prescription medications with specific eligibility criteria, potential contraindications, and dosing protocols that must be managed by a qualified provider. Self-prescribing, unregulated compounding sources, or programs without real clinical oversight can expose patients to serious risk.

At EdenRx, every patient assessment is reviewed by a licensed healthcare provider before any treatment plan is created. This is not a formality — it is the standard of care. A provider review ensures that your health history, current medications, and individual goals are all factored into any recommendation. If you are considering a GLP-1 program, the most important question to ask any platform is: "Who is reviewing my information, and what are their credentials?" EdenRx answers that question clearly. Built from Eden Med Spa — real patients, real treatments.


Think GLP-1 medication might be right for you? Check Your Eligibility — Takes less than 5 minutes. Available to patients in Florida and New York.


Frequently Asked Questions

What is the history of obesity treatment before GLP-1 medications? Obesity treatment has evolved significantly over more than a century — from dangerous fad diets and amphetamine-based pills in the early 20th century, to the brief and harmful Fen-Phen era of the 1990s, to bariatric surgery as the most effective but least accessible option. The development of GLP-1 receptor agonists represents the most clinically significant advancement in that long history.

How do GLP-1 medications work for weight loss? GLP-1 receptor agonists mimic a naturally occurring gut hormone that helps regulate blood sugar, slows stomach emptying, and sends satiety signals to the brain. This combination may reduce appetite and caloric intake, potentially leading to significant weight loss in eligible patients. Results vary, and these medications are intended for use under medical supervision.

Who may qualify for GLP-1 weight loss medications? Eligibility for GLP-1 medications typically depends on BMI, weight-related health conditions, and medical history. Many patients with a BMI of 27 or higher with at least one weight-related condition, or a BMI of 30 or higher, may potentially qualify. Visit our who qualifies for weight loss medication page and complete a free assessment to find out if you may be eligible.

Is telehealth weight loss as effective as in-person treatment? Provider-reviewed telehealth programs follow the same clinical protocols as in-person care and may be equally effective for appropriate candidates. The key factor is whether a licensed medical provider is genuinely involved in reviewing your health information and supervising your treatment plan. EdenRx's model is built around real provider oversight, not automated approvals.

Are GLP-1 medications safe? GLP-1 receptor agonists have been evaluated in large-scale clinical trials and are FDA-approved for weight management in eligible patients. Like all medications, they carry potential side effects and are not appropriate for everyone. A provider review is essential to determine whether these medications are appropriate for your individual health profile.

Is EdenRx available outside Florida and New York? Currently, EdenRx serves patients in Florida and New York only. We are working to expand access to additional states. If you are located in one of these states, you can start your free assessment today to find out if you may qualify for a provider-reviewed weight loss program.


The Long Road to Modern Weight Loss Medicine

The obesity treatment history GLP-1 therapies now define has been marked by as many failures as breakthroughs. From Victorian-era fad diets to the withdrawal of dangerous diet drugs, from the proven-but-limited world of bariatric surgery to the genuine promise of GLP-1 receptor agonists delivered through accessible telehealth platforms — medicine has arrived at a moment of real possibility for patients who have struggled for years without a sustainable solution.

If you live in Florida or New York and are curious whether a provider-reviewed GLP-1 program may be right for you, EdenRx makes it simple to find out. No payment is required to begin, and a licensed provider will review your information before any treatment plan is ever recommended. Individual results vary, and no outcomes are guaranteed — but the science has never been stronger, and the access has never been easier.

Start your journey today. Take the Free Assessment | View Programs & Pricing | Learn About GLP-1

EdenRx is a provider-reviewed telehealth weight loss platform currently serving patients in Florida and New York. All treatment plans are subject to provider review and individual eligibility. Results vary. This content is for informational purposes only and does not constitute medical advice.

See if you qualify in 60 seconds

Provider-reviewed · Only pay if approved · Cancel anytime

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
GLP-1 weight loss obesity treatment semaglutide telehealth weight loss medication obesity history GLP-1 program Florida New York

Share This Article

Share Text

From fad diets to GLP-1 — the history of obesity treatment has led to the most effective medications ever developed. Are you eligible? Find out at tryedenrx.org #GLP1 #WeightLoss #Telehealth

No payment required to start — get up to $50 off your first month.

A licensed provider reviews every case. Only pay if approved. Cancel anytime.

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
Live Activity
134 people online now
1,076 visits today
10 orders shipped today
HIPAA Secure